These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7947279)

  • 1. Pancytopenia in allogeneic marrow transplant recipients: role of cytomegalovirus.
    Bilgrami S; Almeida GD; Quinn JJ; Tuck D; Bergstrom S; Dainiak N; Poliquin C; Ascensao JL
    Br J Haematol; 1994 Jun; 87(2):357-62. PubMed ID: 7947279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancytopenia with hypercellular bone marrow secondary to cytomegalovirus after cardiac transplant.
    Elkhateeb O; Jackson S; Schlech WF; Storm K; Howlett J
    J Heart Lung Transplant; 2009 Jul; 28(7):749-50. PubMed ID: 19560708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and multi-organ failure with fatal outcome: a case report.
    Miszewska-Szyszkowska D; Mikołajczyk N; Komuda-Leszek E; Wieczorek-Godlewska R; Świder R; Dęborska-Materkowska D; Szmidt J; Durlik M
    Ann Transplant; 2015 Mar; 20():169-74. PubMed ID: 25813912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group.
    Ljungman P; Engelhard D; Link H; Biron P; Brandt L; Brunet S; Cordonnier C; Debusscher L; de Laurenzi A; Kolb HJ
    Clin Infect Dis; 1992 Apr; 14(4):831-5. PubMed ID: 1315585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.
    Winston DJ; Ho WG; Bartoni K; Du Mond C; Ebeling DF; Buhles WC; Champlin RE
    Ann Intern Med; 1993 Feb; 118(3):179-84. PubMed ID: 8380243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of cytomegalovirus pneumonitis with ganciclovir and high-dose intravenous immunoglobulin in a bone marrow transplant recipient.
    Chow JM; Lin MT; Chen YC; Chang SC; Su IJ; Tang JL
    J Formos Med Assoc; 1992 Oct; 91(10):996-1000. PubMed ID: 1362680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment.
    Holland HK; Saral R
    Support Care Cancer; 1993 Sep; 1(5):245-9. PubMed ID: 8156234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection.
    Atkinson K; Downs K; Golenia M; Biggs J; Marshall G; Dodds A; Concannon A
    Br J Haematol; 1991 Sep; 79(1):57-62. PubMed ID: 1654994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective pre-emptive therapy with Ganciclovir and specific immunoglobulins for CMV infection in a bone marrow transplanted patient.
    Dentamaro T; Volpi A; Cudillo L; Masi M; Tribalto M; Sordillo P; Salanitro A; Papa G
    Haematologica; 1992; 77(3):284-6. PubMed ID: 1330849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.
    Reed EC; Wolford JL; Kopecky KJ; Lilleby KE; Dandliker PS; Todaro JL; McDonald GB; Meyers JD
    Ann Intern Med; 1990 Apr; 112(7):505-10. PubMed ID: 2156476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in marrow transplantation.
    Boeckh M; Bowden R
    Cancer Treat Res; 1995; 76():97-136. PubMed ID: 7577347
    [No Abstract]   [Full Text] [Related]  

  • 14. In situ hybridization for the detection of cytomegalovirus in blood or bone marrow leucocytes after allogeneic bone marrow transplantation.
    Fest T; Deschaseaux M; Mougin C; Cahn JY; Dupond JL; Herve P
    Br J Haematol; 1994 Mar; 86(3):619-23. PubMed ID: 8043444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.
    Goodrich JM; Mori M; Gleaves CA; Du Mond C; Cays M; Ebeling DF; Buhles WC; DeArmond B; Meyers JD
    N Engl J Med; 1991 Dec; 325(23):1601-7. PubMed ID: 1658652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
    Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
    Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease.
    Einsele H; Ehninger G; Steidle M; Vallbracht A; Müller M; Schmidt H; Saal JG; Waller HD; Müller CA
    Lancet; 1991 Nov; 338(8776):1170-2. PubMed ID: 1682592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin.
    Emanuel D; Cunningham I; Jules-Elysee K; Brochstein JA; Kernan NA; Laver J; Stover D; White DA; Fels A; Polsky B
    Ann Intern Med; 1988 Nov; 109(10):777-82. PubMed ID: 2847609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant.
    Goodrich JM; Bowden RA; Fisher L; Keller C; Schoch G; Meyers JD
    Ann Intern Med; 1993 Feb; 118(3):173-8. PubMed ID: 8380242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.